These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32827646)

  • 1. The role of synaptic microRNAs in Alzheimer's disease.
    Kumar S; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165937. PubMed ID: 32827646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs and synapse turnover in Alzheimer's disease.
    Dalal S; Ramirez-Gomez J; Sharma B; Devara D; Kumar S
    Ageing Res Rev; 2024 Aug; 99():102377. PubMed ID: 38871301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.
    Gowda P; Reddy PH; Kumar S
    Ageing Res Rev; 2022 Jan; 73():101529. PubMed ID: 34813976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective distribution and dynamic modulation of miRNAs in the synapse and its possible role in Alzheimer's Disease.
    Garza-Manero S; Pichardo-Casas I; Arias C; Vaca L; Zepeda A
    Brain Res; 2014 Oct; 1584():80-93. PubMed ID: 24355599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNAs as Early Biomarkers of Alzheimer's Disease: A Synaptic Perspective.
    Siedlecki-Wullich D; Miñano-Molina AJ; Rodríguez-Álvarez J
    Cells; 2021 Jan; 10(1):. PubMed ID: 33435363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse and Composite Roles of miRNA in Non-Neuronal Cells and Neuronal Synapses in Alzheimer's Disease.
    Li X; Chen SC; Ip JPK
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic mitochondrial dysfunction and septin accumulation are linked to complement-mediated synapse loss in an Alzheimer's disease animal model.
    Györffy BA; Tóth V; Török G; Gulyássy P; Kovács RÁ; Vadászi H; Micsonai A; Tóth ME; Sántha M; Homolya L; Drahos L; Juhász G; Kékesi KA; Kardos J
    Cell Mol Life Sci; 2020 Dec; 77(24):5243-5258. PubMed ID: 32034429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging.
    Rivera J; Gangwani L; Kumar S
    Cells; 2023 Feb; 12(5):. PubMed ID: 36899879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing actions of environmental enrichment and Alzheimer's disease on the expression of hippocampal microRNAs in mouse models.
    Barak B; Shvarts-Serebro I; Modai S; Gilam A; Okun E; Michaelson DM; Mattson MP; Shomron N; Ashery U
    Transl Psychiatry; 2013 Sep; 3(9):e304. PubMed ID: 24022509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs Modulate the Pathogenesis of Alzheimer's Disease: An In Silico Analysis in the Human Brain.
    Gugliandolo A; Chiricosta L; Boccardi V; Mecocci P; Bramanti P; Mazzon E
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32846925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction.
    Fu WY; Ip NY
    Semin Cell Dev Biol; 2023 Apr; 139():3-12. PubMed ID: 35918217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptosome microRNAs regulate synapse functions in Alzheimer's disease.
    Kumar S; Orlov E; Gowda P; Bose C; Swerdlow RH; Lahiri DK; Reddy PH
    NPJ Genom Med; 2022 Aug; 7(1):47. PubMed ID: 35941185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of miRNAs in Alzheimer's Disease and Possible Fields of Application.
    Silvestro S; Bramanti P; Mazzon E
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31443326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease.
    Wang X; Liu D; Huang HZ; Wang ZH; Hou TY; Yang X; Pang P; Wei N; Zhou YF; Dupras MJ; Calon F; Wang YT; Man HY; Chen JG; Wang JZ; Hébert SS; Lu Y; Zhu LQ
    Biol Psychiatry; 2018 Mar; 83(5):395-405. PubMed ID: 28965984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-128 as a Regulator of Synaptic Properties in 5xFAD Mice Hippocampal Neurons.
    Shvarts-Serebro I; Sheinin A; Gottfried I; Adler L; Schottlender N; Ashery U; Barak B
    J Mol Neurosci; 2021 Dec; 71(12):2593-2607. PubMed ID: 34151409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selected microRNAs Increase Synaptic Resilience to the Damaging Binding of the Alzheimer's Disease Amyloid Beta Oligomers.
    Zolochevska O; Taglialatela G
    Mol Neurobiol; 2020 May; 57(5):2232-2243. PubMed ID: 31997075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Synaptosomal Proteomics in Alzheimer's Disease.
    Ahmad F; Haque S; Chavda V; Ashraf GM
    Curr Protein Pept Sci; 2021; 22(6):479-492. PubMed ID: 34148536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique Properties of Synaptosomes and Prospects for Their Use for the Treatment of Alzheimer's Disease.
    Dashkova AS; Kovalev VI; Chaplygina AV; Zhdanova DY; Bobkova NV
    Biochemistry (Mosc); 2024 Jun; 89(6):1031-1044. PubMed ID: 38981699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs in Alzheimer Disease - A Therapeutic Perspective.
    Gupta P; Bhattacharjee S; Sharma AR; Sharma G; Lee SS; Chakraborty C
    Curr Alzheimer Res; 2017; 14(11):1198-1206. PubMed ID: 28847283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.